Pharmacological interventions for improving respiratory function in amyotrophic lateral sclerosis

  • Protocol
  • Intervention

Authors

  • Zhan-Miao Yi,

    1. Peking University Third Hospital, Department of Pharmacy, Beijing, China
    Search for more papers by this author
  • Fang Liu,

    1. Peking University Third Hospital, Department of Pharmacy, Beijing, China
    Search for more papers by this author
  • Suo-Di Zhai,

    Corresponding author
    1. Peking University Third Hospital, Department of Pharmacy, Therapeutic Drug Monitoring and Clinical Toxicology Center of Peking University, Beijing, China
    • Suo-Di Zhai, Department of Pharmacy, Therapeutic Drug Monitoring and Clinical Toxicology Center of Peking University, Peking University Third Hospital, 49 North Garden Rd, Haidian District, Beijing, 100191, China. zhaisuodi@163.com.

    Search for more papers by this author
  • Jerry Belsh,

    1. UMDNJ - Robert Wood Johnson Medical School, Neuromuscular & ALS Center, New Brunswick, New Jersey, USA
    Search for more papers by this author
  • Si-Yan Zhan,

    1. School of Public Health, Peking University, Centre for Evidence Based Medicine and Clinical Research, Department of Epidemiology and Biostatistics, Beijing, China
    Search for more papers by this author
  • Philip Schiffman

    1. UMDNJ - Robert Wood Johnson Medical School, Medicine Division of Pulmonary and Critical Care, New Brunswick, New Jersey, USA
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy and safety of pharmacological interventions for providing symptomatic relief or a disease-modifying effect on respiratory function in people with ALS.